The InsiteXccelerator (IX) Pilot grant provides funding and a hand-selected advisor to qualified biomedical researchers to support their commercialization efforts. If you are a biomedical researcher in one of the five northeast corridor IDeA states (New Hampshire, Vermont, Rhode Island, Maine, or Delaware) you may be eligible to apply. Funds are available now. Biomed researchers at all stages of their careers, from early-stage to seasoned researchers, are encouraged to apply. Key benefits of IX Pilot Grant grant include: - Up to $25,000 in funding to advance lab research as well as critical technology de-risking - Two months of on-line course work (4 to 5 hours per week) - Access to self-paced learning content focused on strategies for competitive federal grant funding, how to secure venture capital funding, business planning, and more - Paired with an advisor with expertise relevant to your specific research to strengthen grant-writing skills and submissions for highly competitive federal grants The IX Pilot Program is an opportunity to fast track your biomedical innovation to market. If you are interested in applying, or are not sure if you qualify, contact: cora.castle@insitehub.com
| Website | https://www.insitexccelerator.com/ |
| Employees | 7 (0 on RocketReach) |
| Founded | 2023 |
| Address | 591 Collaboration Way Suite 613, Newark, Delaware 19713, US |
| Industry | Biotechnology Research |
Looking for a particular InsiteXccelerator employee's phone or email?
InsiteXccelerator is based in Newark, Delaware.